Product Description
| Cat Number | AM-370 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Antimicrobial and anticancer peptide |
| Modification | Leucines 3 and 8, and lysines 6,9 and 13 are D enantiomers, C terminal amide |
| Purity | >95% by hplc |
| Biomarker Target | Antibacterials |
| Sequence Three Letter Code | H-Leu-Lys-(D)Leu-Leu-Lys-(D)Lys-Leu-(D)Leu-(D)Lys-Lys-Leu-Leu-(D)Lys-Leu-Leu-NH2 |
| Molecular Formula | C90H174N22O15 |
| Sl Sequence | LKLLKKLLKKLLKLL-NH2 |
| Solubility | Soluble in DMSO |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Papo (2004) Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino Acid Peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res. 64(16) 5779 PMID: 15313920Papo et al (2006) Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide. Cancer Res. 66(10) 5371 PMID: 16707464Ben Hur et al (2022) Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients. J Med Chem. 2022 65(13) 9050 PMID: 35759644 Related areasAll antimicrobial peptides >All immunology research categories >All cancer research categories > |
| Note | The product is for research use only |
Share Item: